Chronic Systemic Therapy With Low-dose Morpholino Oligomers Ameliorates the Pathology and Normalizes Locomotor Behavior in mdx Mice
Page 1 of 1
Chronic Systemic Therapy With Low-dose Morpholino Oligomers Ameliorates the Pathology and Normalizes Locomotor Behavior in mdx Mice
Jon Moulton Mon Nov 29, 2010 10:08 am
Malerba A, Sharp PS, Graham IR, Arechavala-Gomeza V, Foster K, Muntoni F, Wells DJ, Dickson G. Chronic Systemic Therapy With Low-dose Morpholino Oligomers Ameliorates the Pathology and Normalizes Locomotor Behavior in mdx Mice. Mol Ther. 2010 Nov 23. [Epub ahead of print]
Jon Moulton- Posts : 5721
Join date : 2010-03-12
Age : 61
Location : Philomath, Oregon, USA -
Similar topics» Systemic Antisense Therapeutics for Dystrophin and Myostatin Exon Splice Modulation Improve Muscle Pathology of Adult mdx Mice
» Advanced Morpholino Oligomers: A Novel Approach to Antiviral Therapy
» Morpholino treatment improves muscle function and pathology of Pitx1 transgenic mice
» Cell-penetrating peptides enhance systemic delivery of antisense morpholino oligomers
» Ultrasound-enhanced delivery of Morpholino with Bubble liposomes ameliorates the myotonia of myotonic dystrophy model mice
» Advanced Morpholino Oligomers: A Novel Approach to Antiviral Therapy
» Morpholino treatment improves muscle function and pathology of Pitx1 transgenic mice
» Cell-penetrating peptides enhance systemic delivery of antisense morpholino oligomers
» Ultrasound-enhanced delivery of Morpholino with Bubble liposomes ameliorates the myotonia of myotonic dystrophy model mice
Page 1 of 1
Permissions in this forum:
You cannot reply to topics in this forum